Legislation and Legislative Advocacy
The American Hospital Association (AHA) shares resources on health care legislation being considered by the U.S. House and Senate and legislative advocacy opportunities for hospitals and health systems.
Drug shortages threaten the quality of patient care, narrow treatment options and often result in the use of potentially less effective alternative medications, hospital and health system leaders said at a briefing today on Capitol Hill.
The Senate Health, Education, Labor & Pensions Committee today passed by voice vote the Title VIII Nursing Workforce Reauthorization Act.
Members of the House and Senate Telehealth Caucus today introduced the CONNECT for Health Act, AHA-supported legislation that would expand access to telehealth for Medicare patients and remove barriers to its adoption and use by hospitals and other providers.
AHA letter to the Congressional Telehealth Caucus in support of the CONNECT for Health Act of 2019.
The House of Representatives last night passed the Title VIII Nursing Workforce Reauthorization Act (H.R. 728), legislation that would reauthorize federal programs to develop the nursing workforce for five years.
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe Medication Practices today voiced strong support for the Mitigating Emergency Drug Shortages Act.
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe Medication Practices voiced strong support for the Mitigating Emergency Drug Shortages Act (S.2723), which includes provisions recommended by a…
The AHA today submitted comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs.
AHA's comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs.
The House Ways and Means Committee last night voted 24-17 to approve a revised version of the Lower Prescription Drug Costs Now Act.